• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母体血清滴眼液治疗先天性角膜麻醉所致双侧神经营养性角膜病变:病例报告及文献综述

Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review.

作者信息

Giannaccare Giuseppe, Lucisano Andrea, Pellegrini Marco, Scuteri Gianfranco, Mancini Alessandra, Malaventura Cristina, Busin Massimo, Scorcia Vincenzo

机构信息

Department of Ophthalmology, University Magna Græcia of Catanzaro, Catanzaro, Italy.

Department of Ophthalmology, Ospedali Privati Forlì"Villa Igea", Forlì, Italy.

出版信息

Am J Ophthalmol Case Rep. 2022 Feb 18;26:101446. doi: 10.1016/j.ajoc.2022.101446. eCollection 2022 Jun.

DOI:10.1016/j.ajoc.2022.101446
PMID:35243177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8866839/
Abstract

PURPOSE

To report the feasibility and the successful outcomes of a pediatric neurotrophic keratopathy (NK) owing to congenital corneal anesthesia (CCA) treated with allogeneic serum eye drops obtained from the mother as the only therapy.

OBSERVATIONS

A 18-month-old girl with generalized pain insensitivity presented with a large epithelial defect in the right eye (RE) and superficial punctate keratopathy (SPK) in the left eye (LE). Corneal sensitivity was completely absent in both eyes (BE). Peripheral serum eye drops obtained from the mother was prescribed and administered every 2 hours in BE. Two weeks after the beginning of treatment, compete healing of the epithelial defect in the RE was obtained, while the severity of the SPK in the LE markedly improved; in parallel, conjunctival hyperemia disappeared in BE. The treatment was continued over the course of 3 months with good tolerability and neither signs of recurrence of the epithelial defect nor other complications were noted.

CONCLUSIONS AND IMPORTANCE

Allogeneic serum eye drops obtained from the mother are effective in treating pediatric NK owing to CCA. This treatment may represent a readily available and inexpensive option when topical nerve growth factor is unavailable or corneal neurotization is not feasible.

摘要

目的

报告以母亲提供的异体血清滴眼液作为唯一治疗方法,治疗因先天性角膜麻醉(CCA)导致的小儿神经营养性角膜病变(NK)的可行性及成功结果。

观察结果

一名18个月大的女童存在全身疼痛不敏感,右眼出现大的上皮缺损,左眼出现浅层点状角膜炎(SPK)。双眼角膜敏感性完全缺失。开具了从母亲处获取的外周血清滴眼液,并每2小时双眼给药一次。治疗开始两周后,右眼上皮缺损完全愈合,而左眼SPK的严重程度明显改善;同时,双眼结膜充血消失。治疗持续3个月,耐受性良好,未观察到上皮缺损复发迹象或其他并发症。

结论及重要性

母亲提供的异体血清滴眼液治疗因CCA导致的小儿NK有效。当局部神经生长因子不可用或角膜神经化不可行时,这种治疗可能是一种容易获得且廉价的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da0/8866839/4d29097d0b7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da0/8866839/4d29097d0b7f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3da0/8866839/4d29097d0b7f/gr1.jpg

相似文献

1
Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review.母体血清滴眼液治疗先天性角膜麻醉所致双侧神经营养性角膜病变:病例报告及文献综述
Am J Ophthalmol Case Rep. 2022 Feb 18;26:101446. doi: 10.1016/j.ajoc.2022.101446. eCollection 2022 Jun.
2
A case report of pediatric neurotrophic keratopathy in pontine tegmental cap dysplasia treated with cenegermin eye drops.一例用西奈吉明滴眼液治疗脑桥被盖部发育异常所致小儿神经营养性角膜病变的病例报告。
Medicine (Baltimore). 2020 Jul 24;99(30):e20816. doi: 10.1097/MD.0000000000020816.
3
Pediatric Use of Recombinant Human Nerve Growth Factor 20 μg/mL Eye Drops (Cenegermin) for Bilateral Neurotrophic Keratopathy in Congenital Corneal Anesthesia.儿童使用 20μg/ml 重组人神经生长因子滴眼液(Cenegermin)治疗先天性角膜感觉丧失的双侧神经营养性角膜病变。
Cornea. 2021 Feb 1;40(2):228-231. doi: 10.1097/ICO.0000000000002612.
4
Combined Use of Therapeutic Hyper-CL Soft Contact Lens and Insulin Eye Drops for the Treatment of Recalcitrant Neurotrophic Keratopathy.联合使用治疗性高透氧软性隐形眼镜和胰岛素眼药水治疗难治性神经营养性角膜病变。
Cornea. 2024 Jan 1;43(1):120-124. doi: 10.1097/ICO.0000000000003361. Epub 2023 Aug 22.
5
Neurotrophic Keratopathy and Topical Insulin Therapy: A Case Report.神经营养性角膜病变与局部胰岛素治疗:一例报告
Cureus. 2023 Sep 30;15(9):e46242. doi: 10.7759/cureus.46242. eCollection 2023 Sep.
6
New Promising Therapeutic Approach for Refractory Corneal Epithelial Defects.难治性角膜上皮缺损的新的有前景的治疗方法。
Cureus. 2023 May 22;15(5):e39324. doi: 10.7759/cureus.39324. eCollection 2023 May.
7
Neurotrophic keratopathy: current challenges and future prospects.神经营养性角膜病变:当前的挑战与未来展望。
Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035.
8
[Neurotrophic keratopathy--a post-LASIK case report].[神经营养性角膜病变——一例准分子激光原位角膜磨镶术后病例报告]
Klin Monbl Augenheilkd. 2005 Nov;222(11):901-4. doi: 10.1055/s-2005-858800.
9
Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery.眼表 100%血清滴眼剂治疗眼部手术后的角膜上皮缺损。
Biomed Res Int. 2013;2013:521315. doi: 10.1155/2013/521315. Epub 2013 Jul 30.
10
A case of infectious crystalline keratopathy after corneal cross-linking.角膜交联术后感染性结晶性角膜病变1例。
Am J Ophthalmol Case Rep. 2021 Jun 16;23:101139. doi: 10.1016/j.ajoc.2021.101139. eCollection 2021 Sep.

本文引用的文献

1
Neurotrophic Keratitis in a Pediatric Patient With Goldenhar Syndrome and Trigeminal Aplasia Successfully Treated by Corneal Neurotization.一名患有Goldenhar综合征和三叉神经发育不全的小儿患者的神经营养性角膜炎通过角膜神经化成功治愈。
Ophthalmic Plast Reconstr Surg. 2022;38(2):e49-e51. doi: 10.1097/IOP.0000000000002086.
2
Aftermarket effects of cenegermin for neurotrophic keratopathy in pediatric patients.儿童患者神经营养性角膜病变中使用外生性人神经生长因子的影响。
Ocul Surf. 2021 Jul;21:52-57. doi: 10.1016/j.jtos.2021.04.003. Epub 2021 Apr 19.
3
Corneal Neurotization: A Novel Surgical Procedure for Neurotrophic Keratopathy.
角膜神经化:治疗神经营养性角膜病变的新手术。
Cornea. 2022 Apr 1;41(4):403-407. doi: 10.1097/ICO.0000000000002746.
4
Neurotrophic Keratopathy in Pediatric Patients.小儿患者的神经营养性角膜病变
Semin Ophthalmol. 2021 May 19;36(4):289-295. doi: 10.1080/08820538.2021.1896747. Epub 2021 Mar 23.
5
Human recombinant nerve growth factor (Cenegermin) in a patient affected by primary congenital glaucoma with neurotrophic keratopathy.人类重组神经生长因子(西奈吉明)用于一名患有原发性先天性青光眼合并神经营养性角膜病变的患者。
Eur J Ophthalmol. 2022 Jul;32(4):NP78-NP81. doi: 10.1177/1120672121999344. Epub 2021 Mar 3.
6
Pediatric Use of Recombinant Human Nerve Growth Factor 20 μg/mL Eye Drops (Cenegermin) for Bilateral Neurotrophic Keratopathy in Congenital Corneal Anesthesia.儿童使用 20μg/ml 重组人神经生长因子滴眼液(Cenegermin)治疗先天性角膜感觉丧失的双侧神经营养性角膜病变。
Cornea. 2021 Feb 1;40(2):228-231. doi: 10.1097/ICO.0000000000002612.
7
Successful Treatment of a Pediatric Neurotrophic Keratopathy With Cenegermin.西尼格玛治疗儿童神经源性角膜病变的疗效观察。
Cornea. 2021 Apr;40(4):516-518. doi: 10.1097/ICO.0000000000002512.
8
A case report of pediatric neurotrophic keratopathy in pontine tegmental cap dysplasia treated with cenegermin eye drops.一例用西奈吉明滴眼液治疗脑桥被盖部发育异常所致小儿神经营养性角膜病变的病例报告。
Medicine (Baltimore). 2020 Jul 24;99(30):e20816. doi: 10.1097/MD.0000000000020816.
9
Direct Versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopathy: A Multicenter Prospective Comparative Study.直接与间接角膜神经重建术治疗神经营养性角膜病变:一项多中心前瞻性对比研究。
Am J Ophthalmol. 2020 Dec;220:203-214. doi: 10.1016/j.ajo.2020.07.003. Epub 2020 Jul 11.
10
Persistent Corneal Epithelial Defects: A Review Article.持续性角膜上皮缺损:一篇综述文章。
Med Hypothesis Discov Innov Ophthalmol. 2019 Fall;8(3):163-176.